Found 1 articles for: "modified Melasma Area Severity Index"
Tranexamic Acid Mesotherapy for Melasma: An Interventional Study
November 2026 | Volume 25 | Issue 11 | Original Article | 1066 | Copyright © November 2026
Background: Tranexamic acid (TXA), an anti-fibrinolytic agent traditionally used to manage blood loss, has shown promising results in the treatment of melasma. Studies on the eff...
Read More
